Personalised Medicine Approach For Fluoropyrimidine-based Therapies

Please see new guidance from the UK Chemotherapy Board on ‘Personalised Medicine Approach For Fluoropyrimidine-based Therapies’.

Objective of document: To provide clinical staff with guidance as to which patients should receive a DPD test and then subsequently to provide advice to clinical staff on the outcome of that test.

Full guidance can be accessed HERE or found in our resource center in the BOPA website.

Latest News

By BOPA Committee on 30th November 2020

BOPA Executive Committee TCON Minutes

Please see the minutes for all BOPA Executive TCON meetings HERE

Read article
By BOPA Committee on 27th November 2020

DPYD Testing Policy Published by NHS England and NHS Improvement

Dear all, (Note – This statement is for England ONLY) Please find an update from NHS England and NHS Improvement on: Clinical commissioning policy statement for pharmacogenomic testing for DPYD…

Read article
By The BOPA Committee on 19th November 2020

Learning Technologies Awards – The Method, Life in a Day

GOLD AWARD – A Life in a Day – The Best use of Mobile Learning – The Method     ‘A truly inspirational project which has demonstrated a fundamental understanding…

Read article
By BOPA Committee on 28th October 2020

BOPA Update, AGM and Symposium Summary

Thank you so much for supporting BOPA this year.  Please find below an update on the AGM and the BOPA 2020 Symposium. BOPA 2020 AGM – We still need your…

Read article

24th BOPA Symposium 2021

Dates and Venue To Be Confirmed

Everything you need to know